Joel Adams & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Hold
2,305
– – 0.38% 39
2026
Q1
$563K Hold
2,305
– – 0.42% 35
2025
Q4
$477K Hold
2,305
– – 0.36% 42
2025
Q3
$427K Hold
2,305
– – 0.34% 41
2025
Q2
$352K Hold
2,305
– – 0.31% 41
2025
Q1
$382K Hold
2,305
– – 0.34% 38
2024
Q4
$333K Buy
+2,305
New +$357K 0.3% 41

Other funds holding JNJ

Joel Adams & Associates's JNJ Position: Q2 2026 in Review

Joel Adams & Associates held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 2,305 shares worth $585K. The position accounts for 0.38% of the portfolio, ranked #39.

Joel Adams & Associates first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Joel Adams & Associates held 2,305 shares of Johnson & Johnson worth $585K as of Q2 2026.
  • Joel Adams & Associates left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.38% of Joel Adams & Associates's portfolio in Q2 2026, its #39 holding.
  • Joel Adams & Associates first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Joel Adams & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.